Showing results (81-90 of 324) with videos related to
Sort By:
Pageof 33
Cell Cycle (Georgetown, Tex.)|January 12, 2011
Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathwaysLawryn H Kasper, Mary C Thomas, Gerard P Zambetti, et al.Seminars in Oncology|March 20, 2001
Adjuvant and neoadjuvant treatment of breast cancerL Gianni, P Valagussa, M Zambetti, et al.Pediatric Blood & Cancer|March 5, 2005
Biology, clinical characteristics, and management of adrenocortical tumors in childrenCarlos Rodriguez-Galindo, Bonald C Figueiredo, Gerard P Zambetti, et al.Methods in Molecular Biology (Clifton, N.J.)|July 18, 2009
Assays to measure p53-dependent and -independent apoptosisDarren C Phillips, Sean P Garrison, John R Jeffers, et al.Molecular and Cellular Endocrinology|November 2, 2011
The International Pediatric Adrenocortical Tumor Registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumorsRaul C Ribeiro, Emilia M Pinto, Gerard P Zambetti, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 22, 2020
Decoding Neurotransmitter Switching: The Road ForwardHui-Quan Li, Marta Pratelli, Swetha Godavarthi, et al.Allergologia Et Immunopathologia|April 27, 1999
Non-specific hyperreactivity before and after nasal specific immunotherapyF Filiaci, G Zambetti, R Romeo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancerP Valagussa, M Zambetti, S Biasi, et al.Allergologia Et Immunopathologia|November 1, 1994
Local treatment of aspecific nasal hyperreactivity with capsaicinF Filiaci, G Zambetti, A Ciofalo, et al.Immunologic Research|March 20, 2012
The rhapsody of NLRPs: master players of inflammation...and a lot moreLia Paola Zambetti, Federica Laudisi, Ginevra Licandro, et al.Pageof 33